ArticleFrontiers in oncology2021

mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2',4'-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications.

Bashir Lawal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.